ROSEN, LEADING TRIAL ATTORNEYS, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
- Written by Newsfile
New York, New York--(Newsfile Corp. - April 20, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) between March 10, 2021 and December 15, 2023, both dates inclusive (the "Class Period"), of the important June 4, 2024 lead plaintiff deadline.
SO WHAT: If...
